Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Small Cap Fund median (37 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 05 Dec 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Smallcap 250 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Axis Small Cap Fund |
|---|---|
| 05 Dec 2013 | ₹100.00 |
| 27 Dec 2014 | ₹183.72 |
| 18 Jan 2016 | ₹189.31 |
| 07 Feb 2017 | ₹238.26 |
| 01 Mar 2018 | ₹294.51 |
| 23 Mar 2019 | ₹289.21 |
| 13 Apr 2020 | ₹271.83 |
| 04 May 2021 | ₹504.80 |
| 26 May 2022 | ₹621.38 |
| 17 Jun 2023 | ₹808.39 |
| 08 Jul 2024 | ₹1166.73 |
| 29 Jul 2025 | ₹1234.57 |
| 20 Aug 2026 | ₹1378.42 |
| Metric | Axis · Direct NAV ₹137.98 Very High risk ★★★★☆ | Category median Small Cap Fund · 37 funds |
|---|---|---|
| +11.82% | +12.86% | |
| +18.08% | +18.08% | |
| +18.26% | +18.44% | |
| +19.87% | +17.52% | |
| +22.93% | +19.96% | |
| +17.41% | — | |
| +21.38% | +21.45% | |
| +21.50% | +21.03% | |
| +21.05% | +19.53% | |
| Risk | ||
| 14.90% | 17.14% | |
| 0.78 | 0.69 | |
| 1.06 | 0.93 | |
| -34.64% | -32.37% | |
| Nifty Smallcap 250 | — | |
| +2.73% | +2.27% | |
| 0.75 | 0.86 | |
| 84.1% | 88.4% | |
| 69.6% | 77.8% | |
| 0.76% | 0.92% | |
| ₹27,535Cr | ₹4,512Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 12% | 27% | |
| Krishnaa Narayan | — | |
| 05 Dec 2013 | — | |
| 129 | — | |
| 18.6% | — | |
| -2.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.